Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022 at 09:07 AM EDT
Longeveron (NASDAQ: LGVN) received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its lead drug ...
